Galera Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Galera Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Galera Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $53K, a 20.5% increase year-over-year.
  • Galera Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $597K, a 298% increase from 2023.
  • Galera Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $150K, a 43.6% decline from 2022.
  • Galera Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $266K, a 18.2% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $597K +$447K +298% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $150K -$116K -43.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $266K -$59K -18.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $325K -$120K -27% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $445K +$8K +1.83% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $437K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.